Remote Rare Neurology Strategic Account Liaison

Otsuka America Pharmaceutical Inc.; Denver (CO); A distancia; USD 158.000 - 252.000; Jornada completa

Descripción de la vacante

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to support the launch and growth of the FUS-ALS program for ALS patients.

This field-based role focuses on communicating complex clinical data, treatment pathways, and patient access information to ALS Centers of Excellence, healthcare providers, and other stakeholders. The SAL will drive performance while collaborating with internal teams to advance Otsuka’s goals in rare neurology and expand access to therapies and

Formación

• Experience in Biotech/Pharma commercial field strategic roles.
• Experience with new product launches.
• Center of Excellence and IDN navigation experience.
• Rare/Ultra-rare disease experience preferred.
• Cross-functional field team coordination experience.

Responsabilidades

• Communicate complex clinical data, protocols, screening and treatment pathways to ALS centers and stakeholders.
• Educate on disease state and screening/diagnostic pathways; prioritize treatment.
• Develop and maintain relationships with HCPs and key opinion leaders.
• Clarify access and patient support programs to enable prescribing.
• Collaborate with cross-functional teams to drive regional strategy and execution.

Conocimientos

Biotech/Pharma commercial experience

New product launches

KOL engagement

Cross-functional coordination

Region residency

Clinical data fluency

Educación

Bachelor's Degree

Advanced clinical degrees (BSN/RN etc.)

Descripción del empleo

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to support the launch and growth of the FUS-ALS program for ALS patients.

This field-based role focuses on communicating complex clinical data, treatment pathways, and patient access information to ALS Centers of Excellence, healthcare providers, and other stakeholders. The SAL will drive performance while collaborating with internal teams to advance Otsuka’s goals in rare neurology and expand access to therapies and